Resmetirom-eligible population among US adults: An estimation analysis based on NHANES 2017–March 2020
A substantial proportion of U.S. adults meet eligibility criteria for resmetirom treatment, with estimates varying significantly based on the stringency of selection criteria.
Authors
- Eda Kaya (ORCID: https://orcid.org/0000-0002-9293-2811)
- Thi Thuc Anh Phan (ORCID: https://orcid.org/0000-0002-0768-2687)
- Phuc Le (ORCID: https://orcid.org/0000-0003-4788-773X)
- Naim Alkhouri (ORCID: https://orcid.org/0000-0001-9872-2391)
- Yusuf Yılmaz (ORCID: https://orcid.org/0000-0003-4378-4418)
Institutions
- Cleveland Clinic (US)
- Recep Tayyip Erdoğan University (TR)
- Universitätsklinikum Knappschaftskrankenhaus Bochum (DE)
- Arizona Liver Health (US)
- Ruhr University Bochum (DE)
Publication Details
- Journal
- Hepatology Communications
- Published
- 2025-06-19
- DOI
- https://doi.org/10.1097/hc9.0000000000000755
- Citations
- 5
- Primary Topic
- Electrolyte and hormonal disorders
- Type
- article
- Field-Weighted Citation Impact
- 7.59